Metoclopramide for nausea and vomiting of pregnancy: A prospective multicenter international study

American Journal of Perinatology

Volumn 19, Issue 6, 2002, Pages 311-316

  Berkovitch, Matitiahu ^a   Mazzota, Paul ^a   Greenberg, Revital ^a   Elbirt, Daniel ^a   Addis, Antony ^a   Schuler Faccini, Lavinia ^a   Merlob, Paul ^a   Arnon, Judy ^a   Stahl, Bracha ^a   Magee, Laura ^a   Moretti, Myla ^a   Ornoy, Asher ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Metoclopramide; Nausea; Pregnancy; Vomiting

Indexed keywords

AMOXICILLIN; ANTACID AGENT; ANTIHISTAMINIC AGENT; BROMAZEPAM; CEFUROXIME; CODEINE; DIPYRONE; DOPAMINE RECEPTOR BLOCKING AGENT; FAMOTIDINE; HEPARIN; LANSOPRAZOLE; METOCLOPRAMIDE; MORPHINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXAZEPAM; PAPAVERINE; PARACETAMOL; PETHIDINE; PROPYLTHIOURACIL; RANITIDINE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BRAZIL; CANADA; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETOTOXICITY; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; ISRAEL; ITALY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTICENTER STUDY; NAUSEA; PREGNANCY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SMOKING; SPONTANEOUS ABORTION; TERATOGENICITY; VOMITING;

ABNORMALITIES; ADOLESCENT; ADULT; ANTIEMETICS; BRAZIL; CANADA; CASE-CONTROL STUDIES; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; ISRAEL; ITALY; METOCLOPRAMIDE; NAUSEA; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; RISK; VOMITING;

EID: 18544379728     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34469     Document Type: Article

References (27)

1. Klebanoff MA, Mills JL. Is vomiting during pregnancy teratogenic? Br Med J 1986;292:724-726
2. Briggs JS. Vomiting in pregnancy: causes and management. Drugs 1975;9:299-306
3. Walters WA, Humphrey MD. Common medical disorders and their treatment. Drugs 1980;19:455-463
4. Drenth JP, Engles LG. Diabetic gastroparesis: a criterical reappraisal of new treatment strategies. Drugs 1992;44: 537-553
5. Cannon JG. Chemistry of dopaminergic agonists. Adv Neurol 1975;9:177-183
6. Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983;98:86-95
7. Eisner M. Effect of metoclopramide on gastrointestinal motility in man: a manometric study. Dig Dis Sci 1971; 16:409-419
8. Arvela P, Jouppila R, Kauppila A, Pakarina A, Pelkonen O, Tuimala R. Placental transfer and hormonal effects of metoclopramide. Eur J Clin Pharmacol 1983;24:345-348
9. Bylsma-Howell M, Riggs KW, McMorland GH, et al. Placental transport of metoclopramide: assessment of maternal and neonatal effects. Can Anaesth Soc J 1983;30:487-492
10. Sorensen HT, Nielsen GL, Christensen K, Tage-Jensen U, Ekbom A, Baron J. Birth outcome following maternal use of metoclopramide. Br J Clin Pharmacol 2000;49:264-268
11. Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med 2000;343: 445-446
12. Marden PM, Smith DW, McDonald MJ. Congenital anomalies in the newborn infant, including minor variations. J Pediatr 1964;64:357-371
13. Moore KL, Persand TVA. The Developing Human: Clinically Oriented Embryology. Philadelphia: W.B. Saunders; 1983
14. Koren G, Bologa M, Long D, Feldman Y, Shear N. Perception of teratogenic risk by pregnant women exposed to drug and chemicals during the first trimester. Am J Obstet Gynecol 1989;160:1190-1194
15. Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome: a meta-analysis. Br J Obstet Gynecol 1989;96:1312-1318
16. Van Stuijvenberg ME, Schabort I, Labadarios D, Nel TJ. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol 1995;172: 1585-1591
17. Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynecol 1995;102:6-8
18. Newman CGH. Clinical aspects of thalidomide embryopathy: a continuing preoccupation. Teratology 1985;32: 133-144
19. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol 1987;157: 1137-1141
20. Shulman A, Shapiro MS, Bahary G, Shenkman L. Abnormal thyroid function in hyperemesis gravidarum. Acta Obstet Gynecol 1989;68:533-536
21. Koch KL, Stern RM, Vasey M, Botti JJ, Creasy GW, Dwyer A. Gastric dysrhythmia and nausea of pregnancy. Dig Dis Sci 1998;35:961-968
22. Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynecol 1986;5:187-196
23. Newman V, Fullerton JT, Anderson PO. Clinical advances in the management of severe nausea and vomiting during pregnancy. J Obstet Gynecol Neonatal Nurs 1993;22:483-490
24. Shaw J, Brooks PM, McNeil JJ, Moulds RFW, Revenscroft PJ, Smith AJ. The management of nausea and vomiting during pregnancy. Med J Aust 1987;147:290-291
25. Einarson A, Koren G, Bergman V. Nausea and vomiting in pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol 1998;76:1-3
26. Petridou E, Salvanos H, Skalkidou A, Dessypris N, Moustaki M, Trichopoulos D. Are there common triggers of preterm deliveries? Br J Obstet Gynaecol 2001;108:598-604
27. Schardein JL. Chemically Induced Birth Defects. New York: Marcel Dekker; 1985